The medical industry is one of the most dynamically developing areas, where innovations play a key role in ensuring the quality and availability of medical care. Modern technological advances allow us to develop and implement high-tech medical equipment, create advanced treatment and diagnostic methods, and form effective import substitution strategies. In the context of global challenges such as pandemics, sanctions, and demographic changes, the domestic medical industry is faced with the need to accelerate the development of innovative solutions. This article discusses current trends in the field of medical innovation, the specifics of the development and implementation of high-tech equipment, as well as import substitution strategies aimed at increasing the competitiveness of domestic medical technologies.

The development of the medical industry is inextricably linked with global scientific discoveries, the introduction of digital technologies and the use of artificial intelligence in diagnostics and treatment. In recent years, there has been a significant increase in investment in biomedical technologies, nanomedicine, gene and cell technologies. Much attention is paid to the development of robotic surgical systems, high-precision imaging methods and non-invasive diagnostic methods. Digitalization of medicine has a revolutionary impact on the industry: artificial intelligence is used to analyze medical images, process large amounts of data, predict diseases and personalize therapy. 3D bioprinting opens up new horizons in the creation of artificial organs and tissues, and telemedicine makes high-quality medical services available in remote regions. Modern medical devices are becoming miniature, mobile and integrated with cloud technologies, which allows real-time monitoring of patients' condition.

The creation of innovative medical equipment is a complex and lengthy process that includes several key stages: fundamental scientific research, prototyping, clinical trials, certification and commercialization. An interdisciplinary approach that unites specialists in the fields of medicine, engineering, biotechnology and programming plays an important role. One of the key problems faced by developers is the need for strict compliance with international and national safety and efficiency standards. In this regard, innovative companies must invest heavily in testing and certification of products. It is also important to consider intellectual property protection issues, since high competition in the medical technology market requires reliable patenting mechanisms. An example of successful innovative developments is a domestic robotic surgery system that can compete with foreign analogues. Thanks to local production and the use of advanced control algorithms, such systems allow for complex operations to be performed with high precision and minimal trauma to the patient.

IMPORT SUBSTITUTION AS A STRATEGIC DIRECTION OF DEVELOPMENT OF THE MEDICAL INDUSTRY

The import substitution policy in the medical industry is aimed at reducing dependence on foreign supplies, developing national production capacities and forming competitive technologies. In the context of sanctions pressure, domestic enterprises are forced to look for alternative ways of supplying raw materials and components, develop their own analogues of foreign equipment and medicines. The success of import substitution largely depends on government support, including tax incentives, subsidies for scientific research and preferential lending programs. The creation of special economic zones and clusters of medical technologies contributes to the accelerated development of the innovative environment.

Joint projects between medical institutions, universities and manufacturing companies allow for the prompt introduction of the latest technologies into clinical practice. One example of effective import substitution is the development of domestic magnetic resonance imaging devices, which are not inferior in their characteristics to foreign analogues. Thanks to the use of Russian components and software, such devices provide a high level of diagnostics and are available to a wide range of medical institutions. Innovations in the medical industry play a decisive role in ensuring the quality of medical care, developing high-tech equipment and strengthening national competitiveness. Digitalization of medicine, robotization of surgical processes, development of telemedicine and biotechnology open up new opportunities for the diagnosis and treatment of diseases.

The development and implementation of high-tech medical equipment requires significant investment, scientific research and coordination of efforts between government agencies, business and the scientific community. In the context of global challenges and sanctions pressure, the import substitution strategy is becoming an important tool for the development of the domestic medical industry. Prospects for further development are associated with the integration of artificial intelligence, the creation of new materials for medical products, the expansion of personalized medicine and the introduction of environmentally friendly technologies in the production of medical equipment. State support, active cooperation between research and production centers, as well as attracting investment in innovative projects will allow Russia to take a leading position in the field of medical technology and ensure the availability of advanced medical care for the population.

DEVELOPMENT OF ARTIFICIAL INTELLIGENCE AND DIGITAL TECHNOLOGIES IN THE MEDICAL INDUSTRY

One of the most promising areas of innovation in medicine is artificial intelligence (AI). Its implementation can significantly improve the accuracy of diagnostics, reduce the time of diagnosis and optimize treatment processes. Modern machine learning algorithms are already demonstrating high efficiency in analyzing medical images, predicting disease risks and selecting individual treatment regimens. The development of digital twins of patients opens up new horizons in personalized medicine. The creation of virtual models of the body allows for computer simulations of treatment and predicting possible complications. This is especially relevant in oncology, cardiology and transplantology, where the accuracy of forecasts is critical. Augmented and virtual reality (AR/VR) are also widely used in medical practice. Interactive technologies are used to train doctors, plan surgeries and rehabilitate patients. For example, AR systems help surgeons visualize the patient's internal organs in real time, which significantly increases the accuracy of surgical intervention. Blockchain systems provide reliable protection of medical data and allow the creation of decentralized patient databases. This is especially important in the context of the digitalization of medicine, when the confidentiality of information is becoming one of the key issues. The use of blockchain in combination with biometric authentication could revolutionize the way we manage electronic medical records.

BIOTECHNOLOGY AND NEW METHODS OF TREATMENT

Breakthrough technologies in bioengineering open up unique opportunities for the medical industry. One of the most promising areas is gene therapy, which allows treating previously incurable diseases by editing DNA. Modern CRISPR-Cas9 methods allow targeted changes in genetic information, which opens up prospects for treating hereditary diseases, oncology and viral infections. Cell therapy and regenerative medicine are becoming increasingly popular. The use of stem cells to restore damaged tissues and organs is already used in cardiology, orthopedics and neurology. Prospects in this area are associated with the creation of bioengineered organs that in the future will be able to completely replace donor transplants.

Three-dimensional bioprinting is becoming a revolutionary method for creating artificial tissues and organs. Today, technologies for printing skin, cartilage and blood vessels have already been developed. Research is underway to create full-fledged organs, such as the liver and kidneys. Bioprinting opens up opportunities for individual selection of tissues and minimizing the risk of transplant rejection. The development of nanomedicine allows for the creation of new drugs with high delivery accuracy. Nanoparticles can transport active substances directly to affected cells, minimizing side effects and increasing the effectiveness of treatment. The use of nanotechnology is especially promising in oncology, where the accuracy of exposure plays a decisive role.

IMPORT SUBSTITUTION STRATEGIES: PROBLEMS AND SOLUTIONS

Despite the high potential of the domestic medical industry, the import substitution process faces a number of challenges. One of the main problems is dependence on foreign components and technologies. Many critical components, such as microprocessors for medical equipment, specialized materials and biopharmaceutical substances, are still purchased abroad. Successful import substitution requires a comprehensive approach, including:

• Development of our own scientific and technical base. Increased investment in fundamental research, creation of specialized scientific centers and expansion of cooperation with leading universities will accelerate the development of domestic technologies.
• Government support measures. Introduction of tax incentives, subsidies for innovative projects, provision of grants for the development of new medical products and drugs contribute to the growth of competitiveness of domestic products.
• Stimulating venture investments. The development of a startup ecosystem in the field of biotechnology and medical innovation will attract private capital and accelerate the process of commercialization of scientific developments.
• Creation of production clusters. Formation of integrated ecosystems uniting scientific, production and medical organizations will allow to establish a full cycle of development, testing and production of medical technologies.
• Personnel training. The development of educational programs in the field of medical engineering, biotechnology and digital technologies is necessary to provide the industry with highly qualified specialists.

One of the successful examples of import substitution is the development of domestic production of medical products, such as surgical instruments, implants and diagnostic equipment. In recent years, Russian enterprises have launched the production of endoprostheses, medical robots, artificial lung ventilation devices and ultrasound scanners, which are not inferior in quality to foreign analogues. Innovations in the medical industry determine the future of healthcare, providing new methods of diagnosis, treatment and rehabilitation. The introduction of artificial intelligence, digital technologies, bioengineering and nanomedicine opens up enormous prospects for improving the quality of medical care and prolonging people's lives. Import substitution, aimed at reducing dependence on foreign technologies and strengthening national sovereignty in the field of medicine, plays an important role in the development of the industry. A comprehensive strategy including government support, development of scientific research, investment incentives and personnel training will allow Russia to take a leading position in the global medical industry. The future of the medical industry is associated with the integration of advanced technologies, the creation of personalized solutions and ensuring the availability of high-quality medical services. Only active development of innovations and effective coordination of efforts of all market participants will allow the creation of a competitive medical system capable of responding to the challenges of the 21st century.

PROSPECTS FOR THE DEVELOPMENT OF THE MEDICAL INDUSTRY IN THE CONTEXT OF GLOBAL CHALLENGES

Modern challenges such as pandemics, changing demographic structures, environmental issues and the growth of chronic diseases require active implementation of innovations in the medical industry. The globalization of medicine has led to increased competition between countries for the right to be a leader in biotechnology and medical developments. In this context, strategic planning, interdisciplinary research and international cooperation are becoming key factors for success. In the face of uncertainty and rapidly changing realities, the medical industry must adapt to new requirements of society and the state. Innovative solutions aimed at automating processes, developing predictive medicine, producing environmentally friendly medical materials and increasing the availability of medical services will determine the vector of development of the industry. The main areas of future innovations in medicine:

• Individualized medicine. Genetic research, personalized drugs and treatment methods will improve the effectiveness of therapy and minimize side effects.
• Next-generation biotech drugs. The development of recombinant proteins, monoclonal antibodies, and mRNA-based vaccines will lead to safer and more effective drugs.
• Autonomous medical systems. The development of portable diagnostic devices, medical robots and wearable sensors will allow people to monitor their health in real time.
• Green medicine. Reducing the harmful effects of medical waste, developing biodegradable materials for implants and drug packaging will reduce the burden on the environment.
• Innovative methods of brain stimulation, brain-computer interfaces and therapy of neurodegenerative diseases will become the basis of medicine of the future.

ECONOMIC ASPECT OF INNOVATIVE DEVELOPMENT OF THE MEDICAL INDUSTRY

Innovations in medicine not only improve people's quality of life, but also make a significant contribution to the economy. The development of high-tech medical solutions contributes to the growth of new markets, an increase in the country's export potential and the creation of highly skilled jobs. For the effective development of the medical industry, it is necessary to take into account the balance between technological capabilities, economic feasibility and social significance. State support for innovations in the form of grants, subsidies and tax incentives plays a decisive role in the formation of a competitive medical industry. One of the key factors of success is the development of venture capital in the field of medical startups. Investments in innovative companies working in the field of digital medicine, biotechnology and medical equipment help to accelerate the commercialization of scientific developments and bring promising technologies to the market. The economic efficiency of medical innovations is also associated with a reduction in healthcare costs. The use of digital technologies for diagnostics and monitoring of patients reduces the burden on clinics, prevents the development of complications and minimizes hospitalization costs.

GEOPOLITICAL FACTOR AND DEVELOPMENT OF NATIONAL MEDICAL TECHNOLOGIES

In recent years, the medical industry has become the object of geopolitical confrontation, and many countries are seeking autonomy in the production of medical products and equipment. Sanction restrictions, instability of global supply chains and competition for technological leadership are pushing countries to actively develop national medical technologies. In this context, import substitution is becoming not just an economic strategy, but a matter of national security. The creation of an independent system for the production of critical medical products such as antibiotics, oncology drugs, diagnostic tests and surgical instruments is becoming a priority of state policy. To achieve this goal, a comprehensive approach is needed, including:

• Formation of a state program to support domestic medical production.
• Development of strategic partnerships between scientific institutes, industrial enterprises and medical institutions.
• Creation of modern production facilities for the production of competitive medical products.
• Localization of production of key components required for the development of medical equipment and pharmaceuticals.

SOCIAL EFFECTS OF IMPLEMENTING MEDICAL INNOVATIONS

Innovative technologies in medicine have a significant impact on society, improving the quality of life, increasing the availability of medical care and reducing mortality from various diseases. The introduction of telemedicine allows residents of remote regions to receive consultations from highly qualified doctors, and the development of remote patient monitoring helps to promptly identify and correct health problems. The social effect of medical innovations is also manifested in an increase in life expectancy, a decrease in morbidity and the formation of a culture of conscious attitude to health. The development of prevention technologies, including genetic testing and personalized lifestyle recommendations, will help people lead a healthier lifestyle and prevent the development of serious diseases. The introduction of robotic systems in surgery, rehabilitation and patient care not only improves the quality of medical care, but also reduces the physical strain on medical personnel. This is especially important in the context of a shortage of doctors and nurses, as well as an increase in the burden on healthcare systems.

FINAL CONCLUSIONS AND PROSPECTS FOR THE DEVELOPMENT OF MEDICAL INNOVATIONS

The medical industry is experiencing a period of rapid technological development, defining new horizons for diagnostics, treatment and prevention of diseases. Innovations in medicine cover a wide range of areas: from artificial intelligence and digital technologies to bioengineering and nanomedicine. The development and implementation of high-tech medical equipment requires close interaction between science, business and the state. In the context of global challenges, the development of domestic medical technologies, the implementation of an import substitution strategy and the creation of an independent system for the production of medical products are becoming critically important. Government support, venture investments and stimulation of scientific research will become the main drivers of innovative growth in the industry.

The key objective is to create a competitive ecosystem of medical technologies that ensures the availability of advanced medical solutions for the population. The future of the medical industry is associated with the transformation of the healthcare paradigm - the transition from the traditional system of treating diseases to predictive and personalized medicine. Innovations will not only improve the quality of life of people, but also reduce the economic burden on healthcare, forming a more sustainable and effective system of medical care. Medical innovations are becoming an integral part of the development of society, contributing to the improvement of public health, economic growth and technological progress. Russia needs to actively develop medical science and production in order to take a worthy place in the global healthcare system and ensure the long-term sustainability of the national medical industry.

2025 (c) Albert Yuryevich Slinyakov is a leader who unites science, business and the state to create and implement innovative solutions that ensure sustainable development of the economy, industry and international cooperation.